Related Experiment Video
Updated: Jul 3, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Insights
Aortic stenosis (AS) is increasingly diagnosed, with no drug treatments available. Management decisions for symptomatic patients require individualized assessment of symptoms, age, and stenosis severity to balance risks and benefits.
Area of Science:
- Cardiology
- Valvular Heart Disease
Background:
- Aortic stenosis (AS) is a prevalent valvular heart disease.
- Increasing life expectancy and incidental echocardiographic diagnoses contribute to its rising prevalence.
- Currently, no effective pharmacologic treatments exist for AS.
Purpose of the Study:
- To outline the diagnostic and management considerations for aortic stenosis.
- To emphasize the importance of individualized patient assessment for treatment decisions.
Main Methods:
- Review of current clinical practices and guidelines for aortic stenosis management.
- Emphasis on echocardiographic evaluation for stenosis severity assessment.
- Consideration of patient-specific factors including symptoms and life expectancy.
Main Results:
- Symptomatic patients with significant aortic stenosis require surgical referral.
- Management decisions necessitate a comprehensive evaluation of individual patient factors.
- Risk-benefit analysis is crucial for determining the optimal treatment strategy.
Conclusions:
- Effective drug therapy for aortic stenosis is lacking.
- Surgical intervention is the primary treatment for symptomatic severe AS.
- Individualized risk-benefit assessment guides the timing and method of aortic stenosis management.
Abstract:
Aortic stenosis is a form of valvular heart disease that is bound to be seen more and more often by healthcare professionals in the coming years. This is due to the increasing life expectancy and the increasing rate of incidental echocardiographic diagnosis in asymptomatic patients. No effective drug treatment for AS is available. Symptomatic patients with significant AS should be referred for surgery. When deciding the method and timing of management, cardiologists and cardiac surgeons should take into consideration the symptoms present, the patient.'s age (life expectancy) and the echocardiographic evaluation of the severity of stenosis. The riskto- benefit ratio of the various management options should be assessed individually. (Cardiol J 2007; 14: 510-517).
Related Concept Videos
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Aortic Regurgitation IV: Nursing Management
Mitral Stenosis IV: Nursing Management
Atherosclerosis III: Management
Angina IV: Management

